The adult stem cell assay global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Adult Stem Cell Assay Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The adult stem cell assay market size has grown rapidly in recent years. It will grow from $8.88 billion in 2023 to $10.28 billion in 2024 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to rise of regenerative medicine, increasing amount of research interest, growing applications in medicine, rising prevalence of chronic diseases, and rise in approvals of clinical trials.
The adult stem cell assay market size is expected to see rapid growth in the next few years. It will grow to $18.52 billion in 2028 at a compound annual growth rate (CAGR) of 15.9%. The growth in the forecast period can be attributed to increase in the aging population, the growing push towards personalized medicine, growing investments and infrastructure, growing demand for regenerative medicine, and rising expenditure in research-related activities. Major trends in the forecast period include the integration of artificial intelligence and automation, the adoption of organ-on-a-chip technologies, developments in tissue engineering, drug discovery and development, and clinical research.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/adult-stem-cell-assay-global-market-report
Scope Of Adult Stem Cell Assay Market
The Business Research Company’s reports encompass a wide range of information, including:
- Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
- Drivers: Examination of the key factors propelling market growth.
- Trends: Identification of emerging trends and patterns shaping the market landscape.
- Key Segments: Breakdown of the market into its primary segments and their respective performance.
- Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
- Macro Economic Factors: Assessment of broader economic elements impacting the market.
Adult Stem Cell Assay Market Overview
Market Drivers –
The growing demand for regenerative medicine is expected to propel the growth of the adult stem cell assay market going forward. Regenerative medicine encompasses biomedical approaches aimed at replacing, repairing, or restoring normal function to human cells, tissues, or organs damaged by age, disease, trauma, or congenital issues. The aging global population drives demand for regenerative medicine due to its potential to treat age-related diseases such as arthritis and cardiovascular conditions. Adult stem cell assays evaluate differentiation into specific cell types, proliferation, migration, and interactions to verify cell viability and efficacy. These tests are critical for creating safe and effective regenerative medicine, such as stem cell therapies. For instance, in July 2023, according to the report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, and Citeline, a US-based provider of drugs and devices, at the end of Q1 2023, there were 247 gene therapies in Phase II, but this number rose by 5% to reach 260 by the end of Q2. Therefore, the growing demand for regenerative medicine drives the adult stem cell assay market.
Market Trends –
Major companies operating in the adult stem cell assay market are developing an advanced, ready-to-use adult stem cell organoid tubule assay model to improve the predictability of therapeutic outcomes and accelerate the development of personalized treatments. A ready-to-use adult stem cell organoid tubule assay model is a pre-assembled system utilizing organoids created from adult stem cells, designed for immediate application in research. For instance, in March 2023, MIMETAS, a Netherlands-based provider of organ-on-a-chip-based disease models, launched the OrganoReady product line. It is a fully prepared adult stem cell (ASC)-derived organoid tubule-based assay model that removes the complexity of cell culture and tissue creation, allowing for quick experimentation. It includes ASC-derived colon and kidney organoid tubules, optimized for use in mechanistic toxicology and drug-induced organ injury studies. With 64 organoids per plate, they are suitable for medium- to high-throughput screening, providing a robust platform for adult stem cell assays.
The adult stem cell assay market covered in this report is segmented –
1) By Type: Viability Or Cytotoxicity, Isolation And Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis
2) By Application: Regenerative Medicine And Therapy Development, Drug Discovery And Development, Clinical Research
3) By End-User: Government Research Institutes, Private Research Institutes, Industry Research
Get an inside scoop of the adult stem cell assay market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19269&type=smp
Regional Insights –
North America was the largest region in the adult stem cell assay market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adult stem cell assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the adult stem cell assay market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Lonza Group AG, Sartorius AG, Sigma Aldrich Chemicals Pvt. Ltd., STEMCELL Technologies Inc., Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Abcam Plc, R&D Systems Inc., BioLegend Inc., Sino Biological Inc., Cell Signaling Technology, Inc., Enzo Biochem Inc., Creative Bioarray, ScienCell Research Laboratories Inc., Cell Biolabs Inc., Abnova Corporation, American Type Culture Collection, AMSBIO LLC
Table of Contents
- Executive Summary
- Adult Stem Cell Assay Market Report Structure
- Adult Stem Cell Assay Market Trends And Strategies
- Adult Stem Cell Assay Market – Macro Economic Scenario
- Adult Stem Cell Assay Market Size And Growth
…..
- Adult Stem Cell Assay Market Competitor Landscape And Company Profiles
- Key Mergers And Acquisitions
- Future Outlook and Potential Analysis
- Appendix
Read Related Reports:
https://goodprnews.com/higher-education-market-share/
https://topprnews.com/magnetometer-market-size/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
